Snapshot evaluation of acute and chronic heart failure in real-life in Turkey: A follow-up data for mortality

dc.contributor.authorYılmaz, Mehmet Birhan
dc.contributor.authorAksakal, Emrah
dc.contributor.authorAksu, Uğur
dc.contributor.authorAltay, Hakan
dc.contributor.authorYıldırım, Nesligül
dc.contributor.authorÇelik, Ahmet
dc.contributor.authorTokgözoğlu, Lale
dc.date.accessioned2021-11-01T18:14:59Z
dc.date.available2021-11-01T18:14:59Z
dc.date.issued2020
dc.department[Belirlenecek]
dc.description.abstractObjective: Heart failure (HF) is a progressive clinical syndrome. SELFIE-TR is a registry illustrating the overall HF patient profile of Turkey. Herein, all-cause mortality (ACM) data during follow-up were provided. Methods: This is a prospective outcome analysis of SELFIE-TR. Patients were classified as acute HF (AHF) versus chronic HF (CHF) and HF with reduced ejection fraction (HFrEF), HF with mid-range ejection fraction, and HF with preserved ejection fraction and were followed up for ACM. Results: There were 1054 patients with a mean age of 63.3±13.3 years and with a median follow-up period of 16 (7–17) months. Survival data within 1 year were available in 1022 patients. Crude ACM was 19.9% for 1 year in the whole group. ACM within 1 year was 13.7% versus 32.6% in patients with CHF and AHF, respectively (p<0.001). Angiotensin-converting enzyme inhibitor/angiotensin receptor blocker, beta blocker, and mineralocorticoid receptor antagonist were present in 70.6%, 88.2%, and 50.7%, respectively. In the whole cohort, survival curves were graded according to guideline-directed medical therapy (GDMT) scores ?1 versus 2 versus 3 as 28% versus 20.2% versus 12.2%, respectively (p<0.001). Multivariate analysis of the whole cohort yielded age (p=0.009) and AHF (p=0.028) as independent predictors of mortality in 1 year. Conclusion: One-year mortality is high in Turkish patients with HF compared with contemporary cohorts with AHF and CHF. Of note, GDMT score is influential on 1-year mortality being the most striking one on chronic HFrEF. On the other hand, in the whole cohort, age and AHF were the only independent predictors of death in 1 year
dc.identifier.doi10.14744/AnatolJCardiol.2019.87894
dc.identifier.endpage168en_US
dc.identifier.issn2149-2263
dc.identifier.issn2149-2271
dc.identifier.issue3en_US
dc.identifier.pmid32120368
dc.identifier.scopus2-s2.0-85080941417
dc.identifier.scopusqualityQ3
dc.identifier.startpage160en_US
dc.identifier.urihttps://doi.org10.14744/AnatolJCardiol.2019.87894
dc.identifier.urihttps://app.trdizin.gov.tr/makale/TXpRM09UVXhNUT09
dc.identifier.urihttps://hdl.handle.net/11491/7620
dc.identifier.volume23en_US
dc.identifier.wosWOS:000522763500008
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakTR-Dizin
dc.indekslendigikaynakPubMed
dc.institutionauthor[Belirlenecek]
dc.language.isoen
dc.relation.ispartofThe Anatolian Journal of Cardiology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subject[No Keywords]en_US
dc.titleSnapshot evaluation of acute and chronic heart failure in real-life in Turkey: A follow-up data for mortality
dc.typeArticle

Dosyalar